Final Updated: Jan 25, 2022, 01: 44 AM IST
Synopsis
The Competitors Commission of India (CCI) on Monday licensed the proposed acquisition of particular person healthcare firm GlaxoSmithKline Asia Pvt Ltd (GSKAPL) by two other GlaxoSmithKline neighborhood entities.
The Competitors Commission of India (CCI) on Monday licensed the proposed acquisition of particular person healthcare firm GlaxoSmithKline Asia Pvt Ltd (GSKAPL) by two other GlaxoSmithKline neighborhood entities. It also licensed Italian firm Generali Community‘s proposal to prefer its shareholding in Future Generali India Lifestyles Insurance to 71% from the sleek 49%.
(Take the total Industry Files, Breaking Files Events and Most trendy Files Updates on The Economic Times.)
Ranking The Economic Times Files App to get Everyday Market Updates & Are dwelling Industry Files.
…moreless
ETPrime stories of the day
- Advertisement -
